Clear Harbor Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,250
| Closed | -$117K | – | 411 |
|
|
2025
Q1 | $117K | Buy |
35,250
+11,700
| +50% | +$39K | 0.01% | 380 |
|
|
2024
Q4 | $174K | Buy |
23,550
+6,000
| +34% | +$44.4K | 0.01% | 343 |
|
|
2024
Q3 | $165K | Sell |
17,550
-13,250
| -43% | -$124K | 0.01% | 334 |
|
|
2024
Q2 | $247K | Buy |
+30,800
| New | +$247K | 0.02% | 308 |
|
|
2024
Q1 | – | Sell |
-11,000
| Closed | -$89.4K | – | 367 |
|
|
2023
Q4 | $89.4K | Buy |
+11,000
| New | +$89.4K | 0.01% | 328 |
|
|
2022
Q3 | – | Sell |
-6,625
| Closed | -$73K | – | 364 |
|
|
2022
Q2 | $73K | Buy |
+6,625
| New | +$73K | 0.01% | 365 |
|